Canine Coronavirus-Parvovirus Vaccine, Modified Live and Killed Virus

Contents: This product contains the antigens listed above.
Gentamicin and thimerosal added as preservatives.
Indications: For vaccination of healthy dogs 6 weeks of age or older as an aid in the prevention of disease caused by canine coronavirus and canine parvovirus.
Dosage and Administration: Inject one 1 mL dose subcutaneously using aseptic technique. A recommended vaccination schedule should start at or about 6 weeks of age. The presence of maternal antibody is known to interfere with the development of active immunity. Puppies should be revaccinated every 2 to 3 weeks until they are at least 12 weeks of age. All dogs over 12 weeks of age should initially receive one dose of vaccine and a second dose 2 to 3 weeks later. Annual revaccination with one dose is recommended.
InfoVax-ID System: The InfoVax-ID System provides a simple and effective method of recording pertinent information on the vaccines administered to animals in a veterinary practice. For vaccines requiring reconstitution, remove label from both vials and affix both labels to the animal's medical chart.
Precaution(s): Store in the dark at 2° to 7°C (35° to 45°F). Avoid freezing. Shake well. Burn container and all unused contents.
Caution(s): In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package. (9CFRPart 112.6)
In case of anaphylactoid reaction, administer epinephrine.
Presentation: 25 doses (25 x 1 mL vials of vaccine), featuring the InfoVax-ID System.